ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea flag South Korea · Delayed Price · Currency is KRW
941.00
-33.00 (-3.39%)
At close: Apr 20, 2026

KOSDAQ:034940 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
28,99731,29030,32961,37172,957116,484
Market Cap Growth
-7.42%3.17%-50.58%-15.88%-37.37%-24.50%
Enterprise Value
50,54154,50546,30172,29179,771118,025
Last Close Price
936.001010.00979.001981.002355.003760.00
PE Ratio
----130.12-
PS Ratio
0.490.530.480.981.062.02
PB Ratio
1.331.441.061.581.422.41
P/TBV Ratio
1.191.280.991.531.402.37
EV/Sales Ratio
0.850.920.741.151.162.05
EV/EBITDA Ratio
----41.85-
Debt / Equity Ratio
1.251.250.860.450.360.34
Debt / EBITDA Ratio
----9.80-
Net Debt / Equity Ratio
1.141.140.670.340.200.13
Net Debt / EBITDA Ratio
-5.95-5.95-2.59-2.055.37-1.53
Net Debt / FCF Ratio
-4.02-4.02-3.83-5.70-2.42-1.25
Asset Turnover
0.870.870.860.790.830.71
Inventory Turnover
3.103.103.263.284.033.26
Quick Ratio
0.620.620.700.931.241.38
Current Ratio
0.980.981.081.451.761.92
Return on Equity (ROE)
-29.26%-29.26%-30.21%-24.69%1.03%-15.30%
Return on Assets (ROA)
-6.07%-6.07%-8.44%-6.87%-0.36%-5.37%
Return on Capital Employed (ROCE)
-22.80%-22.80%-28.40%-19.50%-0.80%-12.40%
Earnings Yield
-23.47%-21.75%-31.67%-17.13%0.77%-6.91%
FCF Yield
-21.26%-19.70%-16.55%-3.76%-5.79%-4.31%
Buyback Yield / Dilution
0.15%0.15%-0.01%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.